Journals / Cyprus Journal of Medical Sciences / 2021 / Cilt: 6 - Sayı: 1

Protective Effect of Nigella Sativa Oil Against Indomethacin-Related Small Intestine and Gastric Mucosal Damage in Rats

Pages
8–12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hence, our study suggests that NS used together with indomethacin can prevent gastrointestinal damage; thus, this agent can create a new clinical therapeutic principle.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND/AIMS The aim of this study was to investigate the effects of Nigella sativa (NS) oil form on reducing the damage caused by indomethacin in the stomach and duodenum of rats owing to their antioxidant and anti-inflammatory properties.
📊
Key Findings & Data:MATERIAL and METHODS The rats were divided into 4 groups: group 1, saline-treated control group; group 2, NS-treated control group; group 3, saline-treated ulcer group and ulcers caused by indomethacin (30 mg/kg) and administration of physiological serum; group 4, NS-treated ulcer group, which is the group receiving NS oil after administration of indomethacin.
💡
Conclusion & Impact:Hence, our study suggests that NS used together with indomethacin can prevent gastrointestinal damage; thus, this agent can create a new clinical therapeutic principle.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

BACKGROUND/AIMS The aim of this study was to investigate the effects of Nigella sativa (NS) oil form on reducing the damage caused by indomethacin in the stomach and duodenum of rats owing to their antioxidant and anti-inflammatory properties. MATERIAL and METHODS The rats were divided into 4 groups: group 1, saline-treated control group; group 2, NS-treated control group; group 3, saline-treated ulcer group and ulcers caused by indomethacin (30 mg/kg) and administration of physiological serum; group 4, NS-treated ulcer group, which is the group receiving NS oil after administration of indomethacin. At the end of the study, blood samples collected from animals were examined for tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and glutathione (GSH), malondialdehyde (MDA) levels and myeloperoxidase (MPO),and Na+/K+-ATPase activities in gastric and intestinal tissue samples. RESULTS Levels of TNF-α and IL-1β in serum and MDA and MPO values in tissue were found to be higher in the saline-treated ulcer group than in the saline-treated control group. In addition, tissue GSH and Na+/K+-ATPase levels were found to be lower. These values were found to be reversed when comparing NS-treated ulcer group to saline-treated ulcer group. Histopathological findings showed epithelial regeneration and improvement instead of dense tissue damage. CONCLUSION The strong antioxidant and anti-inflammatory effects of NS against potential small intestine and gastric damage were shown using an experimental indomethacin-induced ulcer model in rats. Hence, our study suggests that NS used together with indomethacin can prevent gastrointestinal damage; thus, this agent can create a new clinical therapeutic principle.

🔖

Cite This Article

GÜNAY, E., ÖZKAN, E., ABUOĞLU, H. H., AYKAÇ, A., ÖĞÜNÇ, A. V., KARANLIK, B., ÇETİNEL, Ş., ŞEHİRLİ, A. (2021). Protective Effect of Nigella Sativa Oil Against Indomethacin-Related Small Intestine and Gastric Mucosal Damage in Rats. Cyprus Journal of Medical Sciences, Cilt: 6 - Sayı: 1, 8–12. https://ajindex.com/articles/406894

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Gong J, Zhang Z, Zhang X, Chen F, Tan Y, Li H, Jiang J, et al. Effects and possible mechanisms of Alpinia officinarum ethanol extract on indomethacin-induced gastric injury in rats. Pharm Biol 2018
  2. 56(1): 294-301. [Crossref] 2. Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 2009
  3. 44(9): 879-88. [Crossref] 3. Higuchi K, Yoda Y, Amagase K, Kato S, Tokioka S, MuranoM. Prevetation of NSAID-induced small intestinal mucosal injury: Prophylactic potential of lansoprazol. J Clin Biochem Nutr 2009
  4. 45(2): 125-30. [Crossref] 4. Al-Rowais NA. Herbal medicine in the treatment of diabetes mellitus. Saudi Med J 2002
  5. 23(11): 1327-31. 5. Arslan SO, Gelir E, Armutcu F, Coskun O, Gurel A, Sayan H. The protective effect of thymoquinone on ethanol-induced acute gastric damage in the rats. Nutrit Res 2005
  6. [Crossref] 6. Kanter M, Coskun O, Budancamanak M. Hepatoprotective effects of nigella sativa l and urticadioica l on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbontetrachloride-treated rats. World J Gastroenterol 2005
  7. 11(42): 6684-8. [Crossref] 7. El-Kadi A, Kandil O. The black seed (Nigella sativa) and immunity:its effect on human T cell subset. Fed Proc 1987
  8. Salem ML. Immunomodulatory and antitumor effects of smiltaneous treatment of mice with n-3 and n-6 polyunsatured fatty acids. J Union Arab Biol 2000
  9. Erkin B, Dokmeci D, Altaner S, Turan FN. Gastroprotective effect of L-carnitine on indomethacin-induced gastric mucosal injury in rats: a preliminary study. Folia Med (Plovdiv) 2006
  10. 48(3-4): 86-9. 10. Kato S, Takeuchi K. Alteration of gastric ulcerogenic and healing responses in rats with adjuvant-induced arthritis. Jpn J Pharmacol 2002
  11. 89(1): 1-6. [Crossref] 11. Cotton PB, Shorvon PJ. Analysis of endoscopy and radiography in the diagnosis, follow-up and treatment of peptic ulcer disease. Clin Gastroenterol 1984
  12. 13(2): 383-403. 12. Butt UJ, Shah SAA, Ahmed T, Zahid S. Protective effects of Nigella sativa L. seed extract on lead induced neurotoxicity during development and early life in mouse models. Toxicol Res (Camb) 2017
  13. 7(1): 32-40. [Crossref] 13. Ismail M, Al-Naqeep G, Chan KW. Nigella sativa thymoquinone -rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Rad Biol Med 2010
  14. 48(5): 664-72. [Crossref] 14. Al Mofleh IA